Liang Wang

Liang Wang

Auto-generated profile, based on publicly available information

Liang Wang

Department of Orthopaedics Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University Suzhou China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LWLiang Wang
Liang Wang
FZFei Zhou
Fei Zhou
PZPeng Zhang
Peng Zhang
HWHongzhen Wang
Hongzhen Wang
ZQZhipeng Qu
Zhipeng Qu
YXYing Xu
Ying Xu
Vascularization is fundamental for bone formation and bone tissue homeostasis. However, in human subjects, a direct molecular relationship has not been identified between angiogenesis and agents that promote bone disease or factors related to age. Osteopenia is a condition in which bone mineral density is lower than normal, and it represents a sign of normal aging. Here we tested whether the type H vessel, which was recently identified as strongly positive for CD31 and Endomucin (CD31hiEmcnhi) in mice, is an important indicator of aging and osteopenia in human subjects. We found that age-dependent losses of type H vessels in human bone sections conform to the observations in aged mice. The abundance of human type H vessels and osteoprogenitors may be relevant to changes in the skeletal microarchitecture and advanced osteopenia. Furthermore, ovariectomized mice, a widely used model for postmenopausal osteoporosis, exhibited significantly reduced type H vessels accompanied by reduced osteoprogenitors, which is consistent with impaired bone microarchitecture and osteoporosis, suggesting that this feature is an indicator of bone mass independent of aging. More importantly, administration of desferrioxamine led to significantly increased bone mass via enhanced angiogenesis and increased type H vessels in ovariectomized mice. Altogether, these data represent a novel finding that type H vessels are regulated in aged and osteopenia subjects. The abundance of human type H vessels is an early marker of bone loss and represents a potential target for improving bone quality via the induction of type H vessels.

14 February 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
JXJuan Xu
Juan Xu
SHShuang‐Jian He
Shuang‐Jian He
TXTing‐Ting Xia
Ting‐Ting Xia
YSYu Shan
Yu Shan
LWLiang Wang
Liang Wang
Blood vessels are essential for bone development and metabolism. Type H vessels in bone, named after their high expression of CD31 and Endomucin (Emcn), have recently been reported to locate mainly in the metaphysis, exhibit different molecular properties and couple osteogenesis and angiogenesis. A strong correlation between type H vessels and bone metabolism is now well‐recognized. The crosstalk between type H vessels and osteoprogenitor cells is also involved in bone metabolism‐related diseases such as osteoporosis, osteoarthritis, fracture healing and bone defects. Targeting the type H vessel formation may become a new approach for managing a variety of bone diseases. This review highlighted the roles of type H vessels in bone‐related diseases and summarized the research attempts to develop targeted intervention, which will help us gain a better understanding of their potential value in clinical application.